Treffer: The glycosylation variant at residue 381 of the spike protein contributes to virulence shifts in porcine epidemic diarrhea virus during both natural field transmission and laboratory cell passaging with poor cross-protection.
Original Publication: Baltimore, American Society for Microbiology.
J Virol. 2025 May 20;99(5):e0219324. (PMID: 40237499)
PLoS Pathog. 2025 Jan 22;21(1):e1012886. (PMID: 39841800)
Cell. 2020 Aug 20;182(4):812-827.e19. (PMID: 32697968)
Microb Pathog. 2020 Dec;149:104553. (PMID: 33011361)
Cell. 2025 Mar 20;188(6):1729-1742.e16. (PMID: 39970913)
Arch Virol. 1978;58(3):243-7. (PMID: 83132)
J Virol. 2025 Jul 22;99(7):e0045125. (PMID: 40503881)
Vet Res. 2025 Apr 19;56(1):84. (PMID: 40253364)
Discov Nano. 2025 Mar 3;20(1):48. (PMID: 40029472)
PLoS Pathog. 2024 Jul 15;20(7):e1012348. (PMID: 39008518)
Cell. 2020 Sep 3;182(5):1284-1294.e9. (PMID: 32730807)
mBio. 2022 Apr 26;13(2):e0373921. (PMID: 35285698)
Nat Rev Microbiol. 2023 Mar;21(3):162-177. (PMID: 36653446)
Proc Natl Acad Sci U S A. 2022 Jul 12;119(28):e2119761119. (PMID: 35737823)
Nature. 2021 Apr;592(7852):116-121. (PMID: 33106671)
Transbound Emerg Dis. 2019 Jan;66(1):111-118. (PMID: 30102851)
Emerg Infect Dis. 2012 Aug;18(8):1350-3. (PMID: 22840964)
Virol J. 2016 Apr 22;13:68. (PMID: 27103490)
Cell Host Microbe. 2023 Jul 12;31(7):1170-1184.e7. (PMID: 37402373)
PLoS Pathog. 2023 Nov 9;19(11):e1011788. (PMID: 37943965)
Front Immunol. 2022 Jan 19;12:785293. (PMID: 35126354)
Vet Res. 2025 Aug 29;56(1):172. (PMID: 40883772)
Transbound Emerg Dis. 2020 Jan;67(1):65-79. (PMID: 31381232)
J Virol. 2025 Apr 15;99(4):e0024225. (PMID: 40135879)
Cell Rep. 2021 Jun 29;35(13):109292. (PMID: 34166617)
Int J Biol Macromol. 2025 May;308(Pt 2):142394. (PMID: 40122422)
J Virol. 2020 Aug 17;94(17):. (PMID: 32554697)
Transbound Emerg Dis. 2023 Mar 7;2023:7082352. (PMID: 40303733)
Cell Host Microbe. 2022 Nov 9;30(11):1527-1539.e5. (PMID: 36270286)
J Virol. 2025 Apr 15;99(4):e0209224. (PMID: 40035514)
Proc Natl Acad Sci U S A. 2024 Mar 26;121(13):e2317194121. (PMID: 38502700)
J Virol. 2019 Jul 17;93(15):. (PMID: 31118255)
J Virol. 2024 Oct 22;98(10):e0130924. (PMID: 39254314)
Mol Biol Evol. 2023 Mar 4;40(3):. (PMID: 36869744)
Discov Med. 2025 May;37(196):801-807. (PMID: 40415355)
Mol Cells. 2002 Oct 31;14(2):295-9. (PMID: 12442904)
J Virol. 2025 Jun 17;99(6):e0036625. (PMID: 40439407)
Science. 2021 Mar 12;371(6534):1139-1142. (PMID: 33536258)
Sci Rep. 2019 Feb 21;9(1):2529. (PMID: 30792462)
0 (Antibodies, Neutralizing)
0 (Antibodies, Viral)
Weitere Informationen
The virulence and immunogenicity of porcine epidemic diarrhea virus (PEDV) vary during field circulation and cell culture passage (such as when the GI CV777 strain is attenuated through serial passaging). This study revealed that the glycosylation site mutation at position 381 (N381K) of the S protein is associated with these phenomena. Compared with piglets inoculated with P13 virus, piglets inoculated with P100 (N381K) of virulent GX223 exhibited delayed diarrhea, viral shedding, and mortality. Using the virulent rCH/SX/2016-S <subscript>HNXP</subscript> strain (rPEDV-S <subscript>wt</subscript> ) as the backbone, we generated rPEDV-S <subscript>N381K</subscript> . While both the wild-type and mutant strains showed similar growth in vitro and in 2-day-old piglets, rPEDV-S <subscript>N381K</subscript> caused milder diarrhea and lower mortality. In 5-day-old piglets, the mutant strain also induced delayed viral shedding and milder diarrhea. At 21 days after post-infection, all the piglets were challenged with the parental strain. The pigs in both the rPEDV-S <subscript>N381K</subscript> and rPEDV-S <subscript>wt</subscript> groups produced high IgA/IgG levels, but the rPEDV-S <subscript>N381K</subscript> -inoculated piglets presented higher fecal viral loads and lower neutralizing antibody titers against the parental strain. Molecular modeling suggests that N381K alters antigenic epitope interactions, which may affect virulence and immunogenicity. While this study has the limitation of a relatively small sample size in the animal studies, the results collectively demonstrate that S protein glycosylation mutations influence PEDV virulence and contribute to reduced cross-protective vaccine efficacy, offering important insights for PEDV pathogenesis research and vaccine development.
Importance: Porcine epidemic diarrhea virus (PEDV) continues to cause substantial economic losses in the global swine industry, with emerging strains challenging existing vaccine strategies. This study identifies the N381K glycosylation site mutation in the S protein of PEDV as a factor involved in variations in virulence during natural transmission and laboratory adaptation. Crucially, the mutant induces suboptimal neutralizing immunity against the prevalent strain, revealing a mechanism by which classical-strain vaccines may provide limited protection against currently circulating strains. Our findings reveal how a single glycan modification modulates both pathogenicity and immunogenicity, providing critical insights for the development of effective vaccines against circulating PEDV variants.
The authors declare no conflict of interest.